-
Presentation
Presentation
This curricular unit, focuses on developing the essential competencies required for pharmacists to effectively engage in modern healthcare. It emphasizes the expanding role of pharmacists as integral members of patient care teams, responsible for providing pharmaceutical care, managing medication therapies, and contributing to public health. The fields of action include patient-centered care, medication management, and health education, with intervention areas extending across community pharmacy, collaboration with other healthcare professionals, and the implementation of Pharmaceutical Services. This unit will equips students with the knowledge and practical skills needed to address pharmacotherapeutic follow-up, resolve medication-related problems, and master the use of clinical tools to monitor patient outcomes.
-
Class from course
Class from course
-
Degree | Semesters | ECTS
Degree | Semesters | ECTS
Bachelor; Master Degree | Trimestral | 4
-
Year | Nature | Language
Year | Nature | Language
5 | Mandatory | Português
-
Code
Code
ULHT477-5130
-
Prerequisites and corequisites
Prerequisites and corequisites
Not applicable
-
Professional Internship
Professional Internship
Não
-
Syllabus
Syllabus
Module 1: Introduction to pharmaceutical care Module 2: Medication adherence assessment Module 3: Potentially Inappropriate Medications (PIMs) Module 4: Drug-Related Problems (DRPs) Module 5: Medication Reconciliation and Medication Review Module 6: Cardiovascular Risk Module 7: Pharmaceutical Intervention in Hypertension and Dyslipidemia Module 8: Pharmaceutical Intervention in Diabetes and Obesity Module 9: Pharmaceutical Intervention in Asthma and COPD
-
Objectives
Objectives
In the end of this curricular unit, the students will be able to: Promote the identification, prevention, and resolution of negative outcomes of pharmacotherapy in patients and medication-related problems. Contribute to increasing collaboration between different levels of healthcare. Contribute to the health education of patients. Implement and maintain a systematic intervention for pharmacotherapeutic follow-up in the context of community pharmacy. Master the pathologies applicable to Pharmaceutical Care, relevant pharmacotherapy, biochemical and physiological parameter determinations, and therapeutic objectives for each pathology. Use tools to support the implementation and monitoring of patients in Pharmaceutical Care programs in daily practice, including patient data evaluation, detection and resolution of medication-related problems, and the definition and implementation of care plans.
-
Teaching methodologies
Teaching methodologies
The lectures will be based mainly on the expository model, where the basic concepts will be presented. The following innovative methodologies will be used in the practical classes: Progressive patient simulation - each group of students is assigned a virtual patient with a detailed medication history. As the unit progresses, new health problems or medications are added to their patient profile, requiring ongoing management. Role-play with healthcare team integration - simulation of interdisciplinary team meetings in which students play the role of pharmacist and collaborate with other ‘healthcare professionals’ (represented by classmates or teachers) to solve complex patient cases. Fieldwork - As part of the fieldwork, an observational study will be carried out in a community pharmacy that will allow students to familiarise themselves with the professional environment they will soon encounter during their internship
-
References
References
2023 American Geriatrics Society Beers Criteria(r) Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria(r) for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052-2081. Griese-Mammen, N., Hersberger, K. E., Messerli, M., Leikola, S., Horvat, N., van Mil, J. W. F., & Kos, M. (2018). PCNE definition of medication review: Reaching agreement. International Journal of Clinical Pharmacy, 40(5), 1199-1208. Hepler, C. D., & Strand, L. M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47(3), 533-543. International Pharmaceutical Federation. (2022). Medication review and medicines use review: A toolkit for pharmacists. Ordem dos Farmacêuticos. (2021). Orientações para a revisão da medicação. Pharmaceutical Care Network Europe Association. (2020). Classification for drug-related problems V9.1.
-
Assessment
Assessment
Descrição dos instrumentos de avaliação (individuais e de grupo) ¿ testes, trabalhos práticos, relatórios, projetos... respetivas datas de entrega/apresentação... e ponderação na nota final.
Exemplo:
Descrição
Data limite
Ponderação
Frequência (A)
a definir
40%
Desempenho na resolução dos casos práticos durante o trimestre (B)
a definir
25%
Prova oral (C)
a definir
25%
Participação e assiduidade (D) a definir 10% As ferramentas de inteligência artificial (IA) para a realização do elemento de avaliação B, têm de ser reveladas pelos alunos, identificando o propósito para a sua utilização. Para aferir os conhecimentos obtidos, será realizada prova de avaliação oral com a ponderação de 25% na nota final da UC.
O uso responsável e ético da IA por parte dos alunos, com vista à integridade académica, será discutido em contexto de salaa de aula, tendo em conta as regras definidas nesta FUC
-
Mobility
Mobility
No





